Annual Accounts Payable
$1.38 M
+$761.00 K+123.34%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual accounts payable is $1.38 million, with the most recent change of +$761.00 thousand (+123.34%) on December 31, 2023.
- During the last 3 years, SPRO annual accounts payable has risen by +$223.00 thousand (+19.31%).
- SPRO annual accounts payable is now -66.77% below its all-time high of $4.15 million, reached on December 31, 2019.
Performance
SPRO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.09 M
+$3.39 M+125.89%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly accounts payable is $6.09 million, with the most recent change of +$3.39 million (+125.89%) on September 30, 2024.
- Over the past year, SPRO quarterly accounts payable has increased by +$4.71 million (+341.94%).
- SPRO quarterly accounts payable is now -31.96% below its all-time high of $8.95 million, reached on March 31, 2020.
Performance
SPRO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SPRO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.3% | +341.9% |
| 3 y3 years | +19.3% | +341.9% |
| 5 y5 years | -61.8% | +341.9% |
SPRO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.3% | at high | +944.6% |
| 5 y | 5-year | -66.8% | +123.3% | -32.0% | +944.6% |
| alltime | all time | -66.8% | +123.3% | -32.0% | +993.4% |
Spero Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.09 M(+125.9%) |
| Jun 2024 | - | $2.70 M(-12.1%) |
| Mar 2024 | - | $3.07 M(+122.5%) |
| Dec 2023 | $1.38 M(+123.3%) | $1.38 M(+24.9%) |
| Sep 2023 | - | $1.10 M(-15.8%) |
| Jun 2023 | - | $1.31 M(+124.7%) |
| Mar 2023 | - | $583.00 K(-5.5%) |
| Dec 2022 | $617.00 K(-44.0%) | $617.00 K(-76.1%) |
| Sep 2022 | - | $2.58 M(+50.9%) |
| Jun 2022 | - | $1.71 M(-64.2%) |
| Mar 2022 | - | $4.78 M(+334.2%) |
| Dec 2021 | $1.10 M(-4.7%) | $1.10 M(-65.2%) |
| Sep 2021 | - | $3.16 M(+93.7%) |
| Jun 2021 | - | $1.63 M(-57.3%) |
| Mar 2021 | - | $3.83 M(+231.2%) |
| Dec 2020 | $1.16 M | $1.16 M(-53.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $2.48 M(+58.8%) |
| Jun 2020 | - | $1.56 M(-82.5%) |
| Mar 2020 | - | $8.95 M(+115.8%) |
| Dec 2019 | $4.15 M(+15.1%) | $4.15 M(+64.3%) |
| Sep 2019 | - | $2.52 M(+142.9%) |
| Jun 2019 | - | $1.04 M(+86.5%) |
| Mar 2019 | - | $557.00 K(-84.5%) |
| Dec 2018 | $3.60 M(+3.8%) | $3.60 M(+164.1%) |
| Sep 2018 | - | $1.36 M(+93.5%) |
| Jun 2018 | - | $705.00 K(-28.2%) |
| Mar 2018 | - | $982.00 K(-71.7%) |
| Dec 2017 | $3.47 M(+204.7%) | $3.47 M(+72.6%) |
| Sep 2017 | - | $2.01 M(+47.0%) |
| Jun 2017 | - | $1.37 M(+20.1%) |
| Dec 2016 | $1.14 M(-36.5%) | $1.14 M |
| Dec 2015 | $1.79 M | - |
FAQ
- What is Spero Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Spero Therapeutics?
- What is Spero Therapeutics annual accounts payable year-on-year change?
- What is Spero Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Spero Therapeutics?
- What is Spero Therapeutics quarterly accounts payable year-on-year change?
What is Spero Therapeutics annual accounts payable?
The current annual accounts payable of SPRO is $1.38 M
What is the all time high annual accounts payable for Spero Therapeutics?
Spero Therapeutics all-time high annual accounts payable is $4.15 M
What is Spero Therapeutics annual accounts payable year-on-year change?
Over the past year, SPRO annual accounts payable has changed by +$761.00 K (+123.34%)
What is Spero Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SPRO is $6.09 M
What is the all time high quarterly accounts payable for Spero Therapeutics?
Spero Therapeutics all-time high quarterly accounts payable is $8.95 M
What is Spero Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SPRO quarterly accounts payable has changed by +$4.71 M (+341.94%)